Clinical Trial Update: The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a phosphatidylserine-omega-3 supplement for age-associated memory impairment in elderly participants; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-associated Memory Impairment

Drugs mentioned

• Phosphatidylserine-Omega-3 (phosphatidylserine omega-3 fatty acid combination)

Snippet

Sponsor: Enzymotec | Conditions: Age Associated Memory Impairment | Phase 4 | Status: COMPLETED | Results posted: 2009-11-25